Table 3 Relation of demographic and clinical characteristics with GCKR rs780094 genotype in patients with NAFLD (N = 74)

Sex (men %)

64.3

38.9

50

–

ns

Sex (women %)

35.7

61.1

50

–

ns

Age (years)

40.43 ± 8.67

42.58 ± 8.10

38.29 ± 8.53

− 0.027

ns

BMI (kg/m²)

30.70 ± 3.05

31.30 ± 4.19

32.16 ± 4.59

0.057

ns

Waist circumference (cm)

100.0 ± 7.33

106.0 ± 10.91

101.0 ± 7.53

− 0.033

ns

Hip circumference (cm)

108.0 ± 7.14

115.0 ± 8.36

111.0 ± 7.10

0.011

ns

Weight (kg)

82.44 ± 9.56

88.78 ± 11.59

88.78 ± 11.59

0.136

ns

Height (cm)

167.43 ± 8.93

163.28 ± 10.81

165.0 ± 10.50

0.103

ns

Cholesterol (mg/dl)

176.64 ± 45.27

185.14 ± 35.06

182.17 ± 33.75

− 0.037

ns

Triglycerides (mg/dl)

184.71 ± 68.55

172.64 ± 88.37

187.08 ± 39.37

0.007

ns

HDL-C (mg/dl)

43.00 ± 10.94

43.97 ± 11.79

43.08 ± 11.07

− 0.007

ns

LDL-C (mg/dl)

96.70 ± 40.81

107.77 ± 29.91

101.67 ± 35.29

0.051

ns

ALT (IU/l)

52.21 ± 20.25

44.11 ± 29.10

56.75 ± 23.80

0.012

ns

AST (IU/l)

36.29 ± 10.97

29.61 ± 12.41

36.67 ± 19.04

− 0.010

ns

Fasting glucose (mg/dl)

90.57 ± 8.57

92.06 ± 10.08

88.00 ± 13.32

− 0.005

ns